Incorporating considerations of resources use into grading recommendations

Guideline panellists have differing opinions on whether resource use should influence decisions on individual patients. As medical care costs rise, resource use considerations become more compelling, but panellists may find dealing with such considerations challenging

[1]  A. Garber,et al.  Economic foundations of cost-effectiveness analysis. , 1997, Journal of health economics.

[2]  Gordon H Guyatt,et al.  Users' guide to detecting misleading claims in clinical research reports , 2004, BMJ : British Medical Journal.

[3]  Lelia Duley,et al.  Cost‐effectiveness of prophylactic magnesium sulphate for 9996 women with pre‐eclampsia from 33 countries: economic evaluation of the Magpie Trial , 2006, BJOG : an international journal of obstetrics and gynaecology.

[4]  S. Stringer.  Economic Analysis , 2002, The Laryngoscope.

[5]  D. Altman,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[6]  Gordon H Guyatt,et al.  GrADe : what is “ quality of evidence ” and why is it important to clinicians ? rATING quALITY of evIDeNCe AND STreNGTH of reCommeNDATIoNS , 2022 .

[7]  N. Miller.  Medicaid 2176 home and community-based care waivers: the first ten years. , 1992, Health affairs.

[8]  G. Guyatt,et al.  Users' guides to the medical literature. , 1993, JAMA.

[9]  G. Guyatt,et al.  Going from evidence to recommendations , 2008, BMJ : British Medical Journal.

[10]  D M Eddy,et al.  Comparing benefits and harms: the balance sheet. , 1990, JAMA.

[11]  M. Friedberg,et al.  Evaluation of conflict of interest in economic analyses of new drugs used in oncology. , 1999, JAMA.

[12]  Douglas K Owens,et al.  Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force. , 2006, Chest.

[13]  L. Russell,et al.  Opportunity costs in modern medicine. , 1992, Health affairs.

[14]  MSc Douglas K. Owens MD,et al.  Interpretation of cost-effectiveness analyses , 2007, Journal of General Internal Medicine.